NovaBay Pharmaceuticals Inc. (NBY) Fundamentals

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
SHARE INFORMATION
Market Cap$ 7,018,743
Shares Outstanding64,988,364
Float64,165,419
Percent Float98.73%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 8,421,000
Latest Fiscal EPS$ -0.15
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions41
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months316,980
Institutional Holdings Percent6.2%
Institutional Sold Previous 3 Months153,584
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent4.1
Insider Sold Previous 3 Months582,736
Insider Shares Owned2,220,374
TRADING INFO
52 Week High$ 0.63
52 Week Low$ 0.10
52 Week High Change$ -81.48
21 Day Moving Average$ 0.1431
21 Day Extended Moving Average$ 0.143238
50 Day Moving Average$ 0.2097
50 Day Extended Moving Average$ 0.18549
200 Day Moving Average$ 0.263053
200 Day Extended Moving Average$ 0.289931
10 Day Average Volume1,684,176
20 Day Average Volume1,657,516
30 Day Average Volume1,166,210
50 Day Average Volume1,046,455
Alpha-0.020001
Beta2.9390
Standard Deviation0.475317
R20.103943
7 Day Price Change$ -0.0101
7 Day Percent Change-8.55%
21 Day Price Change$ -0.0722
21 Day Percent Change-40.07%
30 Day Price Change$ -0.1235
30 Day Percent Change-53.35%
Month to Date Price Change$ -0.002
Month to Date Percent Change-1.82%
Quarter to Date Price Change$ -0.002
Quarter to Date Percent Change-1.82%
180 Day Price Change$ -0.206
180 Day Percent Change-65.61%
200 Day Price Change$ -0.1972
200 Day Percent Change-64.61%
Year to Date Price Change$ -0.2686
Year to Date Percent Change-71.32%

NovaBay Pharmaceuticals Inc. (NBY) Key Ratios

PROFITABILITY
EBIT Margin-98.6%
EBITDA Margin-95.3%
Pre-Tax Profit Margin-71.2%
Profit Margin Count-29.15%
Gross Margin57.4%
Profit Margin TOT-29.15%
INCOME STATEMENTS
Revenue$ 8,315,000
Revenue Per Share$ 0.1279
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.30
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio2.60
Leverage Ratio1.80
Quick Ratio1.40
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ 6,142,204
Price to Sales0.844106
Price to Free Cash-0.40
PE High Last 5 Years-2.80
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years-1.50
Price to Tangible Book1.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.90
Invoice Turnover1.80
Assets Turnover0.20
Return Assets-31.00
Return on Equity-41.30
Return on Capital-37.63

NovaBay Pharmaceuticals Inc. (NBY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWithumSmith+Brown, PC
CEOJustin M. Hall
Emplyoees31
Last AuditUE
CIK0001389545
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2000 Powell Street
Suite 1150
Emeryville, CA 94608
Websitehttps://www.novabay.com
Facsimile+1 510 474-1577
Telephone+1 510 899-8800
Emailjhall@novabay.com


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.